Year: 2025
Type: preprint
Study design: Case Report
Abstract: Key clinical message• Provides rare histological evidence (reduced λ deposits on repeat biopsy) of treatment efficacy targeting the pathogenic monoclonal deposit in PGNMID.• Demonstrates the clinical utility of a modified, lower-frequency BD regimen, achieving significant renal benefit while potentially reducing toxicity risks.• Underscores the value of repeat renal biopsy in assessing true pathological response to therapy beyond clinical parameters, revealing subclinical deposit regression.
Authors: Xiaoxia Yang, Di Wang, Shiren Sun
Institutions: Xijing Hospital, Air Force Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Award: G8018765811
OpenAlex ID: W4415127000
Cites:
Cited by:
Related to: